semaglutide super responder Everyone wants to be a to the GLP1s, most people are not. , Super responders are more sensitive to GLP1 medications often at lower doses and lose more weight than average. , And as a What does “super responder” actually
Description
Many prescription drugs, including Zepbound, have whats called an elimination half-life

Novo Nordisk announced that the FDA accepted a new drug application for a 25 mg oral version of semaglutide (Wegovy) for two new indications: Chronic weight management in adults living with obesity or who are overweight with at least one comorbid condition Reduce the risk of major adverse cardiovascular events (MACE) in adults with obesity or overweight with established cardiovascular disease (CVD)

A new long-acting analogue based on liquid crystal technology, CAM2029, was shown by Diego Ferone and coauthors to be highly effective, and indicating that self- or partner-injection can be used, as for lanreotide autogel. That study, Octreotide subcutaneous depot for acromegaly: A randomized, double-blind, placebo-controlled phase 3 trial, ACROINNOVA 1 published in May

Published work on retatrutide sits in metabolic and incretin-receptor pharmacology, where it is examined as a triple GIP/GLP-1/glucagon receptor agonist

Diabetes 59 , 32293239 (2010)
